PharmAus20 Digital Forum, Session 1: COVID-19 lessons from international industry leaders- Critical issues management, and key outcomes from an international perspective.
In an Australian first, Medicines Australia will bring together international industry leaders to discuss COVID-19 lessons – critical issues management, and key outcomes from an international perspective.
Chaired by Dr Anna Lavelle (Chair, Medicines Australia), session 1 will feature:
Mr Thomas Cueni – Director General, International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
Ms Nathalie Moll, Director General, European Federation of Pharmaceutical Industries and Associations (EFPIA)
Dr Richard Torbett, CEO, The Association of the British Pharmaceutical Industry (ABPI)
Dr Graeme Jarvis, CEO, Medicines New Zealand
Plus an address from The Hon Chris Bowen MP, Shadow Minister for Health, and more to be announced shortly...